Convertible Note - MatriSys Bioscience
Investment Firm
Overview
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.
Announced Date
Jan 05, 2017
Funding Type
Convertible Note
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Tech Coast Angels |
Round Details and Background
MatriSys Bioscience raised $1500000 on 2017-01-05 in Convertible Note
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 08, 2018 |  Seed Round - MatriSys Bioscience | 2 | - | undefined |
| Oct 01, 2019 | Venture Round - MatriSys Bioscience | 2 | - | undefined |
| Mar 11, 2021 | Convertible Note - MatriSys Bioscience | 2 | - | 3.0M |
| Jan 05, 2017 | Convertible Note - MatriSys Bioscience | 1 | - | 1.5M |
Recent Activity
There is no recent news or activity for this profile.